{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Daily+Monitoring&page=57", "query": { "intervention": "Daily Monitoring", "page": 57 }, "page_size": 10 }, "pagination": { "page": 57, "page_size": 10, "total_count": 1597, "total_pages": 160, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Daily+Monitoring&page=58&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Daily+Monitoring&page=56&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-26T21:32:57.355Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00719303", "title": "Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fallopian Tube Clear Cell Adenocarcinoma", "Fallopian Tube Endometrioid Adenocarcinoma", "Fallopian Tube Mucinous Adenocarcinoma", "Fallopian Tube Serous Adenocarcinoma", "Fallopian Tube Transitional Cell Carcinoma", "Malignant Ovarian Brenner Tumor", "Ovarian Clear Cell Adenocarcinoma", "Ovarian Endometrioid Adenocarcinoma", "Ovarian Mucinous Adenocarcinoma", "Ovarian Seromucinous Carcinoma", "Ovarian Serous Adenocarcinoma", "Ovarian Transitional Cell Carcinoma", "Primary Peritoneal Serous Adenocarcinoma", "Stage IIA Fallopian Tube Cancer AJCC v6 and v7", "Stage IIA Ovarian Cancer AJCC V6 and v7", "Stage IIB Fallopian Tube Cancer AJCC v6 and v7", "Stage IIB Ovarian Cancer AJCC v6 and v7", "Stage IIC Fallopian Tube Cancer AJCC v6 and v7", "Stage IIC Ovarian Cancer AJCC v6 and v7", "Stage IIIA Fallopian Tube Cancer AJCC v7", "Stage IIIA Ovarian Cancer AJCC v6 and v7", "Stage IIIA Primary Peritoneal Cancer AJCC v7", "Stage IIIB Fallopian Tube Cancer AJCC v7", "Stage IIIB Ovarian Cancer AJCC v6 and v7", "Stage IIIB Primary Peritoneal Cancer AJCC v7", "Stage IIIC Fallopian Tube Cancer AJCC v7", "Stage IIIC Ovarian Cancer AJCC v6 and v7", "Stage IIIC Primary Peritoneal Cancer AJCC v7", "Stage IV Fallopian Tube Cancer AJCC v6 and v7", "Stage IV Ovarian Cancer AJCC v6 and v7", "Stage IV Primary Peritoneal Cancer AJCC v7", "Undifferentiated Fallopian Tube Carcinoma", "Undifferentiated Ovarian Carcinoma" ], "interventions": [ { "name": "Behavioral Dietary Intervention", "type": "BEHAVIORAL" }, { "name": "Compliance Monitoring", "type": "BEHAVIORAL" }, { "name": "Counseling", "type": "OTHER" }, { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Exercise Intervention", "type": "BEHAVIORAL" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Gynecologic Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 1070, "start_date": "2012-06-18", "completion_date": null, "has_results": false, "last_update_posted_date": "2018-02-19", "last_synced_at": "2026-10-26T21:32:57.355Z", "location_count": 687, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Anchorage, Alaska + 452 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT00719303" }, { "nct_id": "NCT02484261", "title": "Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Leukemia" ], "interventions": [ { "name": "Bortezomib", "type": "DRUG" }, { "name": "Pravastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Reuven Schore", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Months", "maximum_age": "21 Years", "sex": "ALL", "summary": "22 Months to 21 Years" }, "enrollment_count": 10, "start_date": "2015-05", "completion_date": null, "has_results": false, "last_update_posted_date": "2023-03-15", "last_synced_at": "2026-10-26T21:32:57.355Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02484261" }, { "nct_id": "NCT04474223", "title": "Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "AVB - Atrioventricular Block", "Fetal AVB" ], "interventions": [ { "name": "Dexamethasone", "type": "DRUG" }, { "name": "IVIG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 1300, "start_date": "2020-08-01", "completion_date": "2029-06-30", "has_results": false, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-10-26T21:32:57.355Z", "location_count": 23, "location_summary": "Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 17 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04474223" }, { "nct_id": "NCT00858273", "title": "Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study B", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 1" ], "interventions": [ { "name": "Antioxidant supplement", "type": "DIETARY_SUPPLEMENT" }, { "name": "Diabetes treatment", "type": "OTHER" }, { "name": "Regular Insulin", "type": "DRUG" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER", "DRUG" ], "sponsor": "Nemours Children's Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "12 Years to 21 Years" }, "enrollment_count": 41, "start_date": "2008-03", "completion_date": "2011-08", "has_results": true, "last_update_posted_date": "2023-05-17", "last_synced_at": "2026-10-26T21:32:57.355Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00858273" }, { "nct_id": "NCT02205762", "title": "LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Langerhans Cell Histiocytosis" ], "interventions": [ { "name": "Prednisone", "type": "DRUG" }, { "name": "Vinblastine", "type": "DRUG" }, { "name": "mercaptopurine", "type": "DRUG" }, { "name": "INDOMETHACIN", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Cytosine Arabinoside", "type": "DRUG" }, { "name": "2-chlorodeoxyadenosine", "type": "DRUG" }, { "name": "hematopoietic stem cell transplantation (RIC-HSCT)", "type": "PROCEDURE" }, { "name": "Intravenous immunoglobulin", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "PROCEDURE", "BIOLOGICAL" ], "sponsor": "North American Consortium for Histiocytosis", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "18 Years", "sex": "ALL", "summary": "Up to 18 Years" }, "enrollment_count": 1400, "start_date": "2016-11-02", "completion_date": "2026-07", "has_results": false, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-10-26T21:32:57.355Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 36 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Madera", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02205762" }, { "nct_id": "NCT07457970", "title": "Community Health Worker Coaching to Reduce Cardiovascular Risk Among Women After a Hypertensive Disorder of Pregnancy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Blood Pressure Monitoring", "Hypertension (HTN)", "Pregnancy" ], "interventions": [ { "name": "Enhanced Care Group", "type": "BEHAVIORAL" }, { "name": "Remote Blood Pressure Monitoring alone", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 240, "start_date": "2026-04-24", "completion_date": "2029-07-15", "has_results": false, "last_update_posted_date": "2026-05-04", "last_synced_at": "2026-10-26T21:32:57.355Z", "location_count": 1, "location_summary": "Columbia, South Carolina", "locations": [ { "city": "Columbia", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07457970" }, { "nct_id": "NCT04219085", "title": "CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gestational Diabetes", "Maternal Complication of Pregnancy" ], "interventions": [ { "name": "Continuous Glucose Monitor", "type": "DEVICE" }, { "name": "Routine Care", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 65, "start_date": "2020-09-01", "completion_date": "2024-08-30", "has_results": true, "last_update_posted_date": "2025-08-28", "last_synced_at": "2026-10-26T21:32:57.355Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT04219085" }, { "nct_id": "NCT00439218", "title": "Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Spinal Muscular Atrophy Type I" ], "interventions": [ { "name": "sodium phenylbutyrate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Westat", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "48 Months", "sex": "ALL", "summary": "2 Months to 48 Months" }, "enrollment_count": 5, "start_date": "2008-01", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2010-11-09", "last_synced_at": "2026-10-26T21:32:57.355Z", "location_count": 5, "location_summary": "Stanford, California • Boston, Massachusetts • New York, New York + 2 more", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00439218" }, { "nct_id": "NCT03987555", "title": "Paclitaxel Therapeutic Drug Monitoring in Cancer Patients", "overall_status": "SUSPENDED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Solid Tumor, Adult", "Metastatic Nonsmall Cell Lung Cancer", "Anatomic Stage IV Breast Cancer AJCC v8", "Metastatic Cervical Carcinoma", "Metastatic Ovarian Carcinoma", "Malignant Uterine Neoplasm", "Vulvar Cancer", "Invasive Breast Cancer", "Metastatic Breast Carcinoma", "Prognostic Stage IV Breast Cancer AJCC v8", "Recurrent Breast Carcinoma", "Recurrent Cervical Carcinoma", "Recurrent Lung Non-Small Cell Carcinoma", "Recurrent Ovarian Carcinoma", "Recurrent Vulvar Carcinoma", "Stage IV Cervical Cancer AJCC v8", "Stage IV Lung Cancer AJCC v8", "Stage IV Vulvar Cancer AJCC v8", "Stage IV Ovarian Cancer AJCC v8", "Stage IVA Cervical Cancer AJCC v8", "Stage IVA Lung Cancer AJCC v8", "Stage IVA Ovarian Cancer AJCC v8", "Stage IVA Vulvar Cancer AJCC v8", "Stage IVB Cervical Cancer AJCC v8", "Stage IVB Lung Cancer AJCC v8", "Stage IVB Ovarian Cancer AJCC v8", "Stage IVB Vulvar Cancer AJCC v8", "Vulva Squamous Cell Carcinoma" ], "interventions": [ { "name": "Blood draws", "type": "OTHER" }, { "name": "QLQ-CIPN20 Survey", "type": "OTHER" }, { "name": "PR-CTCAE Survey", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 55, "start_date": "2019-11-11", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-08-13", "last_synced_at": "2026-10-26T21:32:57.355Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03987555" }, { "nct_id": "NCT05335889", "title": "Wearable Sensors and Artificial Intelligence for Carbohydrate Counting", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "eButton", "type": "DEVICE" }, { "name": "Continuous Glucose Monitoring (CGM)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 12, "start_date": "2022-07-18", "completion_date": "2023-09-22", "has_results": false, "last_update_posted_date": "2024-04-12", "last_synced_at": "2026-10-26T21:32:57.355Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05335889" } ] }